tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AQST Stock Latest News

Aquestive Therapeutics price target raised to $12 from $9 at Citizens JMP
The FlyAquestive Therapeutics price target raised to $12 from $9 at Citizens JMP
16d ago
AQST
Aquestive Therapeutics Secures New Patents for Anaphylm
PremiumCompany Announcements
Aquestive Therapeutics Secures New Patents for Anaphylm
17d ago
8K
AQST
Aquestive Therapeutics issued two additional U.S. patents to Anaphylm
PremiumThe Fly
Aquestive Therapeutics issued two additional U.S. patents to Anaphylm
17d ago
AQST
Aquestive Therapeutics Advances Anaphylm Clinical Development
PremiumCompany Announcements
Aquestive Therapeutics Advances Anaphylm Clinical Development
24d ago
8K
AQST
Aquestive, Veeva, Oklo, BioMarin, TKO: Trending by Analysts
PremiumWeekend Updates
Aquestive, Veeva, Oklo, BioMarin, TKO: Trending by Analysts
1M ago
TKO
AQST
Aquestive Therapeutics Highlights at Global Investor Conference
PremiumCompany AnnouncementsAquestive Therapeutics Highlights at Global Investor Conference
2M ago
8K
AQST
Aquestive Therapeutics price target raised to $8 from $7 at Oppenheimer
Premium
The Fly
Aquestive Therapeutics price target raised to $8 from $7 at Oppenheimer
2M ago
AQST
Aquestive Therapeutics: De-risking and Strategic Positioning for Success in the Type 1 Allergy Market
Premium
Ratings
Aquestive Therapeutics: De-risking and Strategic Positioning for Success in the Type 1 Allergy Market
2M ago
AQST
Salesforce slides, Figma flops after earnings: Morning Buzz
PremiumThe Fly
Salesforce slides, Figma flops after earnings: Morning Buzz
2M ago
AI
GS
Buy Rating Reiterated for Aquestive Therapeutics: Favorable FDA Outlook and Strong Market Potential for Anaphylm
PremiumRatings
Buy Rating Reiterated for Aquestive Therapeutics: Favorable FDA Outlook and Strong Market Potential for Anaphylm
2M ago
AQST
Aquestive Therapeutics Awaits FDA Decision on Anaphylm
PremiumCompany Announcements
Aquestive Therapeutics Awaits FDA Decision on Anaphylm
2M ago
8K
AQST
Aquestive announces FDA to not require advisory committee meeting for Anaphylm
PremiumThe Fly
Aquestive announces FDA to not require advisory committee meeting for Anaphylm
2M ago
AQST
Aquestive Therapeutics initiated with an Outperform at LifeSci Capital
PremiumThe FlyAquestive Therapeutics initiated with an Outperform at LifeSci Capital
2M ago
AQST
Optimistic Buy Rating for Aquestive Therapeutics Driven by Anaphylm’s Market Potential and Strategic Leadership
Premium
Ratings
Optimistic Buy Rating for Aquestive Therapeutics Driven by Anaphylm’s Market Potential and Strategic Leadership
2M ago
AQST
Aquestive Therapeutics’ Earnings Call: Progress Amid Challenges
Premium
Company Announcements
Aquestive Therapeutics’ Earnings Call: Progress Amid Challenges
2M ago
AQST
Aquestive Therapeutics: Advancing Anaphylm and Strategic Preparations Support Buy Rating
PremiumRatings
Aquestive Therapeutics: Advancing Anaphylm and Strategic Preparations Support Buy Rating
2M ago
AQST
Aquestive Therapeutics Announces $85M Stock Offering
PremiumCompany Announcements
Aquestive Therapeutics Announces $85M Stock Offering
2M ago
8K
AQST
Aquestive Therapeutics 21.25M share Secondary priced at $4.00
PremiumThe Fly
Aquestive Therapeutics 21.25M share Secondary priced at $4.00
2M ago
AQST
Aquestive Therapeutics Secures $75M Funding for Anaphylm
PremiumCompany Announcements
Aquestive Therapeutics Secures $75M Funding for Anaphylm
2M ago
8K
AQST
Aquestive Therapeutics announces $75M strategic funding agreement with RTW
PremiumThe FlyAquestive Therapeutics announces $75M strategic funding agreement with RTW
2M ago
AQST
Aquestive Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Aquestive Therapeutics Reports Q2 2025 Financial Results
2M ago
AQST
Aquestive Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Aquestive Therapeutics Reports Q2 2025 Financial Results
2M ago
8K
AQST

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >